← FDA Drug Approvals (Drugs@FDA)
DOCOSANOL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARMA CANADA · Approved 2023-10-26
Drug application
- FDA Application #
ANDA214454- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DOCOSANOL
- Generic name
- DOCOSANOL
- Active ingredients
- DOCOSANOL
- Dosage form
- CREAM
- Route
- TOPICAL
- Marketing status
- Over-the-counter
- Sponsor
- SUN PHARMA CANADA
- Manufacturer
- YYBA Corp
- First approval
- 2023-10-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown